Additionally, serum levels of short-chain fatty acids (SCFAs), vital bacterial metabolites produced in the colon, are lower in elderly individuals (Sanna et al., 2019)
GLP-1 medical weight loss is available statewide in Arizona via HIPAA compliant telehealth, Phoenix, Scottsdale, Tucson, Mesa, Flagstaff, Sedona, Page, and every city in between
For patients in the UK who are seeking effective, evidence-based weight management options, the following treatments are currently available and approved: Semaglutide 2.4 mg (Wegovy): A GLP-1 receptor agonist with MHRA approval for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
Neurodegeneration: Parkinson's disease The Parkinson's hypothesis began with the same kind of signal